Perspectives and experiences with telepharmacy among pharmacists in Canada: A cross-sectional survey

Main Article Content


Telemedicine, Pharmaceutical services, Pharmacists, Pharmacy


Objective: This study aims to understand Canadian pharmacists’ use, experiences, and perspectives of telepharmacy. Methods: We conducted a crosssectional online survey. Individuals were eligible to participate if they were currently a registered, licensed pharmacist practicing in Canada. We collected perspectives of both telepharmacy users and non-users by creating a survey logic that asked specific and shared questions between the two groups. Data was analyzed using descriptive statistics including means and standard deviations (SD) for continuous variables and proportions for categorical variables. Results: Between October and December 2020, 136 pharmacists completed the survey, including 61 (52.6%) telepharmacy users and 55 (47.4%) nonusers. Among those who use telepharmacy, the majority of participants (39, 72.2%) expressed that telepharmacy augmented their clinical practice and feel comfortable managing minor ailments using telepharmacy (41, 80.4%). Among non-users, 45 (84.9%) indicated that telepharmacy will augment their clinical practice and 48 (90.6%) would feel comfortable managing minor ailments using telepharmacy. Important considerations for successful implementation of telepharmacy for those who use telepharmacy included easier system implementation (29, 19.3%), better privacy & data protection (28, 18.7%) and simple to learn technology (23, 15.3%). Conclusion: Despite the growing recognition of benefits of telepharmacy, our findings suggest that utilization among pharmacists in Canada is still quite low. Nonetheless, our study identified areas of consideration for better integration of telepharmacy in pharmacy practice including optimizing workflow, addressing barriers, and providing training to pharmacy students.


Download data is not yet available.
Abstract 213 | pdf Downloads 200


1. American Medical Association. Physicians’ motivations and requirements for adopting digital health Adoption and attitudinal shifts from 2016 to 2019. 2020.
2. Leung V, Tharmalingam S, Cooper J, et al. Canadian community pharmacists’ use of digital health technologies in practice. Can Pharm J (Ott). 2016;149(1):38-45.
3. World Health Organization. Telemedicine: opportunities and developments in member states: report on the second global survey on eHealth. Geneva, Switzerland: World Health Organization; 2010;93 p.
4. Berman M, Fenaughty A. Technology and managed care: patient benefits of telemedicine in a rural health care network. Health Econ. 2005;14(6):559-73.
5. Bashshur R, Doarn CR, Frenk JM, et al. Telemedicine and the COVID-19 pandemic, lessons for the future. Telemedicine and e-Health. 2020;26(5):571-3.
6. American Medical Association. COVID-19: AMA’s recent and ongoing advocacy efforts. 
7. Committee on Pediatric Workforce. The use of telemedicine to address access and physician workforce shortages. American Academy of Pediatrics. 2015;136(1):202-9.
8. Webster L, Spiro RF. Health information technology: a new world for pharmacy. Journal of the American Pharmacists Association.2010;50(2):e20-34.
9. Canadian Society of Hospital Pharmacists. Telepharmacy: guidelines. 2018.
10. Niznik JD, He H, Kane-Gill SL. Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: a systematic review. Research in Social and Administrative Pharmacy. 2018;14(8):707–17.
11. Ameri A, Salmanizadeh F, Keshvardoost S, et al. Investigating pharmacists’ views on telepharmacy: prioritizing key relationships, barriers, and benefits. Journal of Pharmacy Technology. 2020;36(5):171–8.
12. Park JY, Min J. Exploring Canadian pharmacy students’ e-health literacy: a mixed method study. Pharm Pract (Granada).2020;18(1):1747.